[Craif Co., Ltd.] Craif is a special sponsor of the Tokyo Shimbun Memorial Forum “100 Years of Life: Healthy Mind and Body Methods by Naoko Takahashi x Minoru Kamata” to convey the importance of cancer prevention and early detection.
Craif Co., Ltd. Press release: November 14, 2024 Craif is a special sponsor of the Tokyo Shimbun Memorial Forum “100 Years of Life: Healthy Mind and Body Methods by Naoko Takahashi x Minoru Kamata” to convey the importance of cancer prevention and early detection. Craif Co., Ltd. (location: Bunkyo-ku, Tokyo, CEO: Ryuichi Onose, hereinafter “Craif”) is a special sponsor of the Tokyo Shimbun 140th Anniversary Forum “100 Years of Life: How to Healthy Your Mind and Body: Naoko Takahashi x Minoru Kamata.”
https://prcdn.freetls.fastly.net/release_image/41883/207/41883-207-4a353d6c0bbc969fd7c1522913d748bf-1920×1080.jpg
countermeasures (Importance of cancer screening/Things to be aware of in cancer prevention/Pancreatic cancer that is difficult to detect early) ・Archive video of the day https://youtu.be/tEpgrQx72gI https://youtu.be/eL6_dOCKe6M ・List of forum contents Posting date: October 17, 2024 Media: TBS NEWS DIG Title: “Naoko Takahashi thinks about how to maintain a healthy mind and body in order to survive in the era of 100-year lifespans” Article link
https://newsdig.tbs.co.jp/articles/-/1495593?display=1 Posting date: October 18, 2024 Media: Tokyo Shimbun morning edition/web version Title: “Naoko Takahashi and Minoru Kamata talk about how to maintain a healthy mind and body” Article link
https://www.tokyo-np.co.jp/article/362029 Posting date: November 14, 2024 Media: Tokyo Shimbun morning edition/web version Title: “How to maintain a healthy mind and body by Naoko Takahashi and Minoru Kamata” ■ About “My Signal Series” “MySignal Series” is a cancer risk test that leads to prevention and early detection. This series includes “MySignal Scan,” a test that uses microRNA x AI to evaluate cancer risk with high precision, “MySignal Light,” a test that more easily evaluates cancer risk, and genetic tests specific to cancer. It consists of “MySignal Navi” and “MySignal Check,” a test that helps monitor and prevent DNA damage. All tests can be performed without putting any strain on the body, simply by collecting urine or saliva. Through four tests, you can learn about your own
constitutional risks and help prevent the onset of symptoms by monitoring DNA damage on a daily basis. It is a comprehensive cancer countermeasure that aims to support the early detection of cancers that cannot be prevented, and to promote cancer prevention and early detection. Please see the website for details. https://misignal.jp/ MySignal series is not a medical device. The risk is determined by statistically calculating the analyzed information, and it does not replace the medical practice of “diagnosing” whether or not you have cancer, and even if the risk is determined to be low. This does not necessarily mean that you will not get cancer or that you will not get cancer in the future. ■ About Craif Craif is a venture company founded in 2018 from Nagoya University. We have the basic technology “NANO IP(R)︎ (NANO Intelligence Platform)” that detects disease-related biological substances such as microRNA with high accuracy from easily collected body fluids such as urine. Craif is working on the development of tests using NANO IP(R)︎ to realize early detection of cancer and medical care tailored to each individual. [Company Profile] Company name: Craif Inc. (pronunciation: Craif, English notation: Craif Inc.) Representative: Representative Director Ryuichi Onose Established: May 2018 Capital: 100 million yen (as of March 1, 2024) Business: Research and development of next-generation tests for early detection of diseases mainly in the cancer field and realization of personalized medicine, provision of urine cancer test “My Signal (R)︎” Head Office: ITP Hongo Office 5F, 2-25-7 Yushima, Bunkyo-ku URL: https://craif.com/